Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
European Long-acting Antipsychotics in Schizophrenia Trial
DRKS00007568Phase 4Completed
- Sponsor
- European Group for Research in Schizophrenia
- Start
- Jun 2015
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 16
01
Overview
Phase 4, randomised trial of aripiprazole, paliperidone and paliperidone palmitate in schizophrenia (4 arms), sponsored by European Group for Research in Schizophrenia. Started Jun 2015; status: completed.
02
Drugs
aripiprazolepaliperidonepaliperidone palmitate
03
Conditions
schizophrenia
Beyond the preview
Go deeper on DRKS00007568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00007568.